ISIN | CH0226274212 |
---|---|
Valor Number | 22627421 |
Bloomberg Global ID | UBANF US |
Fund Name | UBS ETF (CH) - MSCI Switzerland hedged to USD (USD) A-dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The UBS ETF (CH) – MSCI Switzerland 100% hedged to USD is an exchange traded fund incorporated in Switzerland. The objective of the Fund is to deliver the net total return performance of the MSCI Switzerland 100% hedged to USD and allow intraday trading. |
Peculiarities |
Current Price * | 26.61 USD | 16.04.2025 |
---|---|---|
Previous Price * | 26.65 USD | 15.04.2025 |
52 Week High * | 29.70 USD | 20.03.2025 |
52 Week Low * | 24.28 USD | 17.04.2024 |
NAV * | 26.61 USD | 16.04.2025 |
Issue Price * | 26.61 USD | 16.04.2025 |
Redemption Price * | 26.61 USD | 16.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 402,517,089 | |
Unit/Share Assets *** | 402,517,089 | |
Trading Information SIX |
YTD Performance | +1.68% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
---|---|---|
YTD Performance (in CHF) | -8.91% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
1 month | -10.12% |
17.03.2025 - 16.04.2025
17.03.2025 16.04.2025 |
3 months | -1.33% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -2.18% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +9.91% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +15.09% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | +11.54% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +54.03% |
16.04.2020 - 16.04.2025
16.04.2020 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 16.04.2025 |
Nestle SA | 17.81% | |
---|---|---|
Roche Holding AG | 14.12% | |
Novartis AG Registered Shares | 13.99% | |
Zurich Insurance Group AG | 6.38% | |
UBS Group AG | 6.01% | |
Compagnie Financiere Richemont SA Class A | 5.75% | |
ABB Ltd | 5.20% | |
Holcim Ltd | 3.66% | |
Swiss Re AG | 3.32% | |
Lonza Group Ltd | 3.07% | |
Last data update | 15.04.2025 |
TER | 0.25% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.23% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |